Designed for senior regulatory leaders, this program sharpens high-level communication, strategic decision-making, and risk management skills. It equips participants with proven techniques to align stakeholders, foster inclusion, and navigate complex, high-stakes environments with clarity and confidence.
Strategic communication skills are essential for regulatory professionals serving in top-level positions — and those who want to get there.
During the RAPS Advanced Strategic Communication Certificate Program, you will employ your critical thinking skills as you collaborate with your peers to analyze case studies, solve problems, and practice communication techniques you can apply immediately at your job.
Session 1
Session 2
Session 3
Over the course of these four online sessions, senior regulatory professionals with years of experience will guide you to:
Deliver high-impact, executive-level presentations to senior regulatory officials that convey credibility, influence decision-making, and advance strategic outcomes.
Communicate executive-level presentations that clearly explain and defend regulatory positions, enabling you to make informed, risk-based decisions in response to health authority challenges.
Build and lead cross-functional teams with complementary skills to operate cohesively to achieve your organization’s strategic objectives.
Effectively communicate critical updates to your staff through structured, recurring touchpoints that address key initiatives, emerging issues, and organizational impact.
Oversee the dissemination of sensitive information across your organization to prevent adverse repercussions.
With a group of your peers, you will employ critical thinking skills in real time as you collaborate to analyze case studies, solve problems, and practice communication techniques you can apply immediately at your job.
RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to [email protected]. Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.
Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email [email protected] with the event title, name of the original registrant and the contact information for the new attendee.
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected].



Sr. Director, Regulatory Affairs, Johnson & Johnson MedTech Vision

President, Compliance-Alliance LLC
Nancy Singer is president of Compliance-Alliance LLC. She is on the faculty of George Washington University School of Medicine and Health Sciences and teaches classes for FDA Staff Colleges and FDA District Offices. Previously, she served as special counsel for the Advanced Medical Technology Association. For her efforts to improve communication between the government and the regulated industry, Nancy received Vice President Gore’s Reinventing Government Hammer Award and the FDA commissioner’s Special Citation. She began her career as an attorney with the United States Department of Justice doing litigation for FDA enforcement cases. Subsequently she was a partner at the law firm of Kleinfeld, Kaplan and Becker. Nancy is a retired commander in the Navy Reserve.
Principal, DeRisio Group, LLC
Richard DeRisio is a retired medical device executive who collaborates on the development and presentation of training courses for regulatory affairs and quality system professionals. Early in his career, Richard worked in FDA’s Washington-area headquarters offices supporting field operations, managing foreign inspections of medical device and pharmaceutical manufacturers and, in CDRH’s Office of Compliance, reviewing compliance actions, conducting industry training, and serving as the Office’s sterilization sciences expert.After serving at FDA, Richard led global and divisional clinical, quality, regulatory and government affairs organizations at Abbott, J&J, Covidien, and Pfizer, among other companies. His experience encompasses cardiothoracic, electrophysiology, robotic, ophthalmology, and wound healing devices. Prior to retiring, Richard was VP, Medical Health Services, Americas Region for the German notified body TÜV SÜD. In that role, Richard’s organization was responsible for CE-Mark approval of medical devices manufactured in North America.
Sr. Director, Regulatory Affairs, Johnson & Johnson MedTech Vision
Rosanne Melikian leads a global regulatory affairs team responsible for new product development and life cycle management of medical devices designed to treat cataracts and glaucoma. Her portfolio includes cataract extraction systems, laser cataract devices, intraocular lens implants and insertion systems and ophthalmic viscosurgical devices (OVDs).
Rosanne began her career at Abbott in a hybrid role that combined regulatory affairs with research science. She now oversees global regulatory approvals and life cycle management for Johnson & Johnson Surgical Vision’s largest business franchise. She is also committed to talent development within the regulatory affairs organization, has supported critical business development projects, and actively participates in US and international device standards meetings. Rosanne frequently presents to health authorities such as the FDA, Health Canada, and European notified bodies on novel technologies and clinical trials.
:
https://www.linkedin.com/in/rosanne-melikian-phd-msrs-rac-044a31109/